Effects of in vivo modulation of splenic natural killer cell activity on the growth of spleen-seeking tumour variants.

A novel tumour system has been used to study the effect of natural killer cells on tumour growth by using agents which modify natural killer cell activity. The tumour cells are hybridoma cells which secrete antibody specific for red blood cells so that tumour growth can be quantitated by a haemolyti...

Full description

Bibliographic Details
Main Authors: Skinner, M. A., Thompson, K., Ezaki, T., Marbrook, J.
Format: Online
Language:English
Published: 1987
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001739/
id pubmed-2001739
recordtype oai_dc
spelling pubmed-20017392009-09-10 Effects of in vivo modulation of splenic natural killer cell activity on the growth of spleen-seeking tumour variants. Skinner, M. A. Thompson, K. Ezaki, T. Marbrook, J. Research Article A novel tumour system has been used to study the effect of natural killer cells on tumour growth by using agents which modify natural killer cell activity. The tumour cells are hybridoma cells which secrete antibody specific for red blood cells so that tumour growth can be quantitated by a haemolytic plaque assay. Spleen-seeking variants have been derived from original hybrids which are sensitive to natural killer cells. Treatment of mice with polyinosinic-polycytidylic acid substantially enhanced natural killer cell activity and correlated closely with a reduction in the growth of the hybridoma tumour cells in the spleen and life extension. Conversely, a single injection of anti-asialo GM, antibody resulted in a substantial increase in the number of plaque forming splenic tumour cells and virtual elimination of natural killer cell activity. These data demonstrate the important role of natural killer cells in constraining the growth of a tumour of B cell origin and establishes the usefulness of this tumour model in studying the biology of effects on tumour growth. 1987-03 /pmc/articles/PMC2001739/ /pubmed/3552015 Text en
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Skinner, M. A.
Thompson, K.
Ezaki, T.
Marbrook, J.
spellingShingle Skinner, M. A.
Thompson, K.
Ezaki, T.
Marbrook, J.
Effects of in vivo modulation of splenic natural killer cell activity on the growth of spleen-seeking tumour variants.
author_facet Skinner, M. A.
Thompson, K.
Ezaki, T.
Marbrook, J.
author_sort Skinner, M. A.
title Effects of in vivo modulation of splenic natural killer cell activity on the growth of spleen-seeking tumour variants.
title_short Effects of in vivo modulation of splenic natural killer cell activity on the growth of spleen-seeking tumour variants.
title_full Effects of in vivo modulation of splenic natural killer cell activity on the growth of spleen-seeking tumour variants.
title_fullStr Effects of in vivo modulation of splenic natural killer cell activity on the growth of spleen-seeking tumour variants.
title_full_unstemmed Effects of in vivo modulation of splenic natural killer cell activity on the growth of spleen-seeking tumour variants.
title_sort effects of in vivo modulation of splenic natural killer cell activity on the growth of spleen-seeking tumour variants.
description A novel tumour system has been used to study the effect of natural killer cells on tumour growth by using agents which modify natural killer cell activity. The tumour cells are hybridoma cells which secrete antibody specific for red blood cells so that tumour growth can be quantitated by a haemolytic plaque assay. Spleen-seeking variants have been derived from original hybrids which are sensitive to natural killer cells. Treatment of mice with polyinosinic-polycytidylic acid substantially enhanced natural killer cell activity and correlated closely with a reduction in the growth of the hybridoma tumour cells in the spleen and life extension. Conversely, a single injection of anti-asialo GM, antibody resulted in a substantial increase in the number of plaque forming splenic tumour cells and virtual elimination of natural killer cell activity. These data demonstrate the important role of natural killer cells in constraining the growth of a tumour of B cell origin and establishes the usefulness of this tumour model in studying the biology of effects on tumour growth.
publishDate 1987
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001739/
_version_ 1611401947245445120